Genomic Evolution of Breast Cancer Metastasis and Relapse
Guy's Hospital · Wellcome Sanger Institute · +24 more institutions
Abstract
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in large numbers, despite patients with metastatic breast cancer having dismal survival. We sequenced whole genomes or a panel of 365 genes on 299 samples from 170 patients with locally relapsed or metastatic breast cancer. Several lines of analysis indicate that clones seeding metastasis or relapse disseminate late from primary tumors, but continue to acquire mutations, mostly accessing the same mutational processes active in the primary tumor. Most distant metastases acquired driver mutations not seen in the primary tumor, drawing from a wider repertoire of cancer genes than early drivers. These include a number…
Citation impact
- FWCI
- 25.70
- Percentile
- 100%
- References
- 58
Authors
30- LYLucy Yates
Guy's Hospital, Wellcome Sanger Institute
- SKStian Knappskog
Haukeland University Hospital, University of Bergen
- DCDavid C. Wedge
Wellcome Sanger Institute, Open Data Institute, University of Oxford
- JHJames H. R. Farmery
University of Cambridge, Cancer Research UK
- SGSantiago González
European Bioinformatics Institute, Wellcome Sanger Institute
Topics & keywords
- Breast cancer
- Metastasis
- Primary tumor
- Metastatic breast cancer
- Gene
- Cancer
- Biology
- Cancer research
- Good health and well-being
Funding
- UDU.S. Department of EnergyAwards: DE-AC52-06NA25396, AC52-06NA25396
- BCBreast Cancer Research Foundation
- WWellcomeAward: FC001202
- EHEuropean Hematology Association
- KKreftforeningen
- WTWellcome TrustAward: FC001202
- FCFrancis Crick InstituteAward: FC001202
- CRCancer Research UKAwards: A17197, C14303, C14303/A17197, FC001202
- UOUniversity of Cambridge
- NONederlandse Organisatie voor Wetenschappelijk OnderzoekAward: C14303/A17197
- NFNorges Forskningsråd
- BFBergens Forskningsstiftelse
- HUHaukeland Universitetssjukehus
- HWHutchison Whampoa Limited
- NNNational Nuclear Security AdministrationAward: DE-AC52-06NA25396
- MRMedical Research CouncilAward: FC001202
- LALos Alamos National LaboratoryAwards: AC52-06NA25396, DE-AC52-06NA25396